<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01491009</url>
  </required_header>
  <id_info>
    <org_study_id>GU-154</org_study_id>
    <nct_id>NCT01491009</nct_id>
  </id_info>
  <brief_title>Comparison of Remifentanil With Dexmedetomidine or Midazolam in Regards of Sedation Effectivity and Postoperative Cognitive Functions in Cystoscopies</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gazi University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gazi University</source>
  <brief_summary>
    <textblock>
      The aim of the study was to compare the effects of remifentanil-dexmedetomidine and
      remifentanil-midazolam with mini-mental state examination (MMSE) in monitored anesthesia care
      (MAC) patients undergoing cystoscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Forty patients undergoing cystoscopy receiving remifentanil infusion of 0.05 microgram per
      kg-1 min-1 were randomized into two groups: Either dexmedetomidine 1 microgram per kg -1
      (GroupD) or midazolam 0.2 mg kg-1h-1 (GroupM) were administered intravenously for the first
      10 minutes. Subsequently anesthesia was maintained by using the bispectral index(BIS) as a
      continuous infusion of dexmedetomidine 0.2-0.7 microgram per kg-1h-1 or midazolam 0.05-0.15
      mgkg-1h-1. Heart rate, mean arterial pressure, MMSE, sedation and the patient's and surgeon's
      satisfaction were determined.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2006</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">February 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Degree of sedative efficiency</measure>
    <time_frame>During cystoscopy procedure</time_frame>
    <description>Bispectral Index (BIS) was used.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Degree of cognitive functions</measure>
    <time_frame>Postoperative 60 minutes</time_frame>
    <description>mini-mental state examination(MMSE) test was used.</description>
  </primary_outcome>
  <enrollment type="Actual">40</enrollment>
  <condition>Postoperative Cognitive Functions</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil</intervention_name>
    <description>IV infusion</description>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>IV infusion</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with indication of cystoscopy must be able to have sedation

        Exclusion Criteria:

          -  hypersensitivity to drugs used

          -  morbid obesity

          -  coronary disease

          -  diabetes mellitus and other endocrinologic diseases

          -  pregnancy

          -  psychomotor diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ayşe Arpacı, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gazi University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Füsun Bozkırlı, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Gazi University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gazi University Faculty of Medicine Hospital</name>
      <address>
        <city>Ankara</city>
        <zip>06100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2011</study_first_submitted>
  <study_first_submitted_qc>December 12, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 13, 2011</study_first_posted>
  <last_update_submitted>December 12, 2011</last_update_submitted>
  <last_update_submitted_qc>December 12, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 13, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gazi University</investigator_affiliation>
    <investigator_full_name>Ayşe Hande Arpacı</investigator_full_name>
    <investigator_title>Dr. at Department of Anaesthesiology and Reanimation</investigator_title>
  </responsible_party>
  <keyword>Dexmedetomidine</keyword>
  <keyword>midazolam</keyword>
  <keyword>remifentanil</keyword>
  <keyword>mini-mental state examination</keyword>
  <keyword>monitored anaesthesia care</keyword>
  <keyword>cystoscopy</keyword>
  <keyword>sedation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

